Inositols: from established knowledge to novel approaches
- Autores
- Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; Bizzarri, Mariano; Laganà, Antonio Simone; Chan, Shiao Yng; Bevilacqua, Arturo; Pkhaladze, Lali; Benvenga, Salvatore; Stringaro, Annarita; Barbaro, Daniele; Appetecchia, Marialuisa; Aragona, Cesare; Espinola, Maria Salomè Bezerra; Cantelmi, Tonino; Cavalli, Pietro; Chiu, Tony T.; Copp, Andrew J.; D'Anna, Rosario; Dewailly, Didier; di Lorenzo, Cherubino; Diamanti Kandarakis, Evanthia; Marín, Imelda Hernández; Hod, Moshe; Kamenov, Zdravko; Kandaraki, Eleni; Monastra, Giovanni; Oliva, Mario Montanino; Nestler, John E.; Nordio, Maurizio; Ozay, Ali C.; Papalou, Olga; Porcaro, Giuseppina; Prapas, Nikos; Roseff, Scott; Vazquez, Monica Hebe; Vucenik, Ivana; Wdowiak, Artur
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.
Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Unfer, Vittorio. Università di Modena e Reggio Emilia; Italia
Fil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; Italia
Fil: Soulage, Christophe O.. Inserm; Francia
Fil: Greene, Nicholas D.. University College London; Estados Unidos
Fil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; Italia
Fil: Chan, Shiao Yng. National University of Singapore; Singapur
Fil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; Georgia
Fil: Benvenga, Salvatore. Università degli Studi di Messina; Italia
Fil: Stringaro, Annarita. Istituto Superiore di Sanita; Italia
Fil: Barbaro, Daniele. Ospedale Civile Di Livorno; Italia
Fil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; Italia
Fil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; Italia
Fil: Cavalli, Pietro. Humanitas Research Hospital; Italia
Fil: Chiu, Tony T.. IVF Centre; China
Fil: Copp, Andrew J.. University College London; Estados Unidos
Fil: D'Anna, Rosario. Università degli Studi di Messina; Italia
Fil: Dewailly, Didier. Université de Lille; Francia
Fil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; Italia
Fil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; Grecia
Fil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; México
Fil: Hod, Moshe. Universitat Tel Aviv; Israel
Fil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Kandaraki, Eleni. Hygeia Hospital; Grecia
Fil: Monastra, Giovanni. Systems Biology Group Lab; Italia
Fil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Nestler, John E.. Virginia Commonwealth University; Estados Unidos
Fil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; Italia
Fil: Ozay, Ali C.. Near East University Hospital; Chipre
Fil: Papalou, Olga. Hygeia Hospital; Grecia
Fil: Porcaro, Giuseppina. Azienda USL UMBRIA ; Italia
Fil: Prapas, Nikos. Iakentro; Grecia
Fil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados Unidos
Fil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Vucenik, Ivana. University of Maryland; Estados Unidos
Fil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin); - Materia
-
AROMATASE
D-CHIRO-INOSITOL
EPIMERASE
FSH
GDM
MYO-INOSITOL
NEURAL TUBE DEFECTS
PCOS
STEROIDOGENESIS
TESTOSTERONE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/203888
Ver los metadatos del registro completo
id |
CONICETDig_f0efa61993e4c1ed8e4bbfebb6d8d9ba |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/203888 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Inositols: from established knowledge to novel approachesDinicola, SimonaUnfer, VittorioFacchinetti, FabioSoulage, Christophe O.Greene, Nicholas D.Bizzarri, MarianoLaganà, Antonio SimoneChan, Shiao YngBevilacqua, ArturoPkhaladze, LaliBenvenga, SalvatoreStringaro, AnnaritaBarbaro, DanieleAppetecchia, MarialuisaAragona, CesareEspinola, Maria Salomè BezerraCantelmi, ToninoCavalli, PietroChiu, Tony T.Copp, Andrew J.D'Anna, RosarioDewailly, Didierdi Lorenzo, CherubinoDiamanti Kandarakis, EvanthiaMarín, Imelda HernándezHod, MosheKamenov, ZdravkoKandaraki, EleniMonastra, GiovanniOliva, Mario MontaninoNestler, John E.Nordio, MaurizioOzay, Ali C.Papalou, OlgaPorcaro, GiuseppinaPrapas, NikosRoseff, ScottVazquez, Monica HebeVucenik, IvanaWdowiak, ArturAROMATASED-CHIRO-INOSITOLEPIMERASEFSHGDMMYO-INOSITOLNEURAL TUBE DEFECTSPCOSSTEROIDOGENESISTESTOSTERONEhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Unfer, Vittorio. Università di Modena e Reggio Emilia; ItaliaFil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; ItaliaFil: Soulage, Christophe O.. Inserm; FranciaFil: Greene, Nicholas D.. University College London; Estados UnidosFil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; ItaliaFil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; ItaliaFil: Chan, Shiao Yng. National University of Singapore; SingapurFil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; ItaliaFil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; GeorgiaFil: Benvenga, Salvatore. Università degli Studi di Messina; ItaliaFil: Stringaro, Annarita. Istituto Superiore di Sanita; ItaliaFil: Barbaro, Daniele. Ospedale Civile Di Livorno; ItaliaFil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; ItaliaFil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; ItaliaFil: Cavalli, Pietro. Humanitas Research Hospital; ItaliaFil: Chiu, Tony T.. IVF Centre; ChinaFil: Copp, Andrew J.. University College London; Estados UnidosFil: D'Anna, Rosario. Università degli Studi di Messina; ItaliaFil: Dewailly, Didier. Université de Lille; FranciaFil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; ItaliaFil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; GreciaFil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; MéxicoFil: Hod, Moshe. Universitat Tel Aviv; IsraelFil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; BulgariaFil: Kandaraki, Eleni. Hygeia Hospital; GreciaFil: Monastra, Giovanni. Systems Biology Group Lab; ItaliaFil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; BulgariaFil: Nestler, John E.. Virginia Commonwealth University; Estados UnidosFil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; ItaliaFil: Ozay, Ali C.. Near East University Hospital; ChipreFil: Papalou, Olga. Hygeia Hospital; GreciaFil: Porcaro, Giuseppina. Azienda USL UMBRIA ; ItaliaFil: Prapas, Nikos. Iakentro; GreciaFil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados UnidosFil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Vucenik, Ivana. University of Maryland; Estados UnidosFil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin);MDPI2021-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/203888Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-301661-65961422-0067CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910575info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:43:37Zoai:ri.conicet.gov.ar:11336/203888instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:43:37.539CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Inositols: from established knowledge to novel approaches |
title |
Inositols: from established knowledge to novel approaches |
spellingShingle |
Inositols: from established knowledge to novel approaches Dinicola, Simona AROMATASE D-CHIRO-INOSITOL EPIMERASE FSH GDM MYO-INOSITOL NEURAL TUBE DEFECTS PCOS STEROIDOGENESIS TESTOSTERONE |
title_short |
Inositols: from established knowledge to novel approaches |
title_full |
Inositols: from established knowledge to novel approaches |
title_fullStr |
Inositols: from established knowledge to novel approaches |
title_full_unstemmed |
Inositols: from established knowledge to novel approaches |
title_sort |
Inositols: from established knowledge to novel approaches |
dc.creator.none.fl_str_mv |
Dinicola, Simona Unfer, Vittorio Facchinetti, Fabio Soulage, Christophe O. Greene, Nicholas D. Bizzarri, Mariano Laganà, Antonio Simone Chan, Shiao Yng Bevilacqua, Arturo Pkhaladze, Lali Benvenga, Salvatore Stringaro, Annarita Barbaro, Daniele Appetecchia, Marialuisa Aragona, Cesare Espinola, Maria Salomè Bezerra Cantelmi, Tonino Cavalli, Pietro Chiu, Tony T. Copp, Andrew J. D'Anna, Rosario Dewailly, Didier di Lorenzo, Cherubino Diamanti Kandarakis, Evanthia Marín, Imelda Hernández Hod, Moshe Kamenov, Zdravko Kandaraki, Eleni Monastra, Giovanni Oliva, Mario Montanino Nestler, John E. Nordio, Maurizio Ozay, Ali C. Papalou, Olga Porcaro, Giuseppina Prapas, Nikos Roseff, Scott Vazquez, Monica Hebe Vucenik, Ivana Wdowiak, Artur |
author |
Dinicola, Simona |
author_facet |
Dinicola, Simona Unfer, Vittorio Facchinetti, Fabio Soulage, Christophe O. Greene, Nicholas D. Bizzarri, Mariano Laganà, Antonio Simone Chan, Shiao Yng Bevilacqua, Arturo Pkhaladze, Lali Benvenga, Salvatore Stringaro, Annarita Barbaro, Daniele Appetecchia, Marialuisa Aragona, Cesare Espinola, Maria Salomè Bezerra Cantelmi, Tonino Cavalli, Pietro Chiu, Tony T. Copp, Andrew J. D'Anna, Rosario Dewailly, Didier di Lorenzo, Cherubino Diamanti Kandarakis, Evanthia Marín, Imelda Hernández Hod, Moshe Kamenov, Zdravko Kandaraki, Eleni Monastra, Giovanni Oliva, Mario Montanino Nestler, John E. Nordio, Maurizio Ozay, Ali C. Papalou, Olga Porcaro, Giuseppina Prapas, Nikos Roseff, Scott Vazquez, Monica Hebe Vucenik, Ivana Wdowiak, Artur |
author_role |
author |
author2 |
Unfer, Vittorio Facchinetti, Fabio Soulage, Christophe O. Greene, Nicholas D. Bizzarri, Mariano Laganà, Antonio Simone Chan, Shiao Yng Bevilacqua, Arturo Pkhaladze, Lali Benvenga, Salvatore Stringaro, Annarita Barbaro, Daniele Appetecchia, Marialuisa Aragona, Cesare Espinola, Maria Salomè Bezerra Cantelmi, Tonino Cavalli, Pietro Chiu, Tony T. Copp, Andrew J. D'Anna, Rosario Dewailly, Didier di Lorenzo, Cherubino Diamanti Kandarakis, Evanthia Marín, Imelda Hernández Hod, Moshe Kamenov, Zdravko Kandaraki, Eleni Monastra, Giovanni Oliva, Mario Montanino Nestler, John E. Nordio, Maurizio Ozay, Ali C. Papalou, Olga Porcaro, Giuseppina Prapas, Nikos Roseff, Scott Vazquez, Monica Hebe Vucenik, Ivana Wdowiak, Artur |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
AROMATASE D-CHIRO-INOSITOL EPIMERASE FSH GDM MYO-INOSITOL NEURAL TUBE DEFECTS PCOS STEROIDOGENESIS TESTOSTERONE |
topic |
AROMATASE D-CHIRO-INOSITOL EPIMERASE FSH GDM MYO-INOSITOL NEURAL TUBE DEFECTS PCOS STEROIDOGENESIS TESTOSTERONE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects. Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; Italia Fil: Unfer, Vittorio. Università di Modena e Reggio Emilia; Italia Fil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; Italia Fil: Soulage, Christophe O.. Inserm; Francia Fil: Greene, Nicholas D.. University College London; Estados Unidos Fil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; Italia Fil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; Italia Fil: Chan, Shiao Yng. National University of Singapore; Singapur Fil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; Italia Fil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; Georgia Fil: Benvenga, Salvatore. Università degli Studi di Messina; Italia Fil: Stringaro, Annarita. Istituto Superiore di Sanita; Italia Fil: Barbaro, Daniele. Ospedale Civile Di Livorno; Italia Fil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; Italia Fil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; Italia Fil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; Italia Fil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; Italia Fil: Cavalli, Pietro. Humanitas Research Hospital; Italia Fil: Chiu, Tony T.. IVF Centre; China Fil: Copp, Andrew J.. University College London; Estados Unidos Fil: D'Anna, Rosario. Università degli Studi di Messina; Italia Fil: Dewailly, Didier. Université de Lille; Francia Fil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; Italia Fil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; Grecia Fil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; México Fil: Hod, Moshe. Universitat Tel Aviv; Israel Fil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; Bulgaria Fil: Kandaraki, Eleni. Hygeia Hospital; Grecia Fil: Monastra, Giovanni. Systems Biology Group Lab; Italia Fil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; Bulgaria Fil: Nestler, John E.. Virginia Commonwealth University; Estados Unidos Fil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; Italia Fil: Ozay, Ali C.. Near East University Hospital; Chipre Fil: Papalou, Olga. Hygeia Hospital; Grecia Fil: Porcaro, Giuseppina. Azienda USL UMBRIA ; Italia Fil: Prapas, Nikos. Iakentro; Grecia Fil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados Unidos Fil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Vucenik, Ivana. University of Maryland; Estados Unidos Fil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin); |
description |
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/203888 Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-30 1661-6596 1422-0067 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/203888 |
identifier_str_mv |
Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-30 1661-6596 1422-0067 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910575 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268613871927296 |
score |
13.13397 |